# Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)

> **NCT01380951** · PHASE4 · UNKNOWN · sponsor: **The Fifth People's Hospital of Suzhou** · enrollment: 120 (estimated)

## Conditions studied

- Liver Cirrhosis
- Chronic Hepatitis B

## Interventions

- **DRUG:** telbivudine

## Key facts

- **NCT ID:** NCT01380951
- **Lead sponsor:** The Fifth People's Hospital of Suzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2012-12
- **Final completion:** 2013-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380951, "Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01380951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*